Case study: Achieving a 7-week study start-up in a first in human autoimmune study
A U.S. biopharmaceutical company’s first in human autoimmune study in Australia required rapid start up in a highly competitive environment. Through design simplification and a parallel regulatory strategy, Parexel enabled site start up in just 7 weeks (~45% faster than standard), delivering site initiation visit ahead of schedule and achieving on time first dosing with no safety findings.
Related Insights
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
Blog
The future of patient recruitment: Building a more connected ecosystem
Sep 9, 2026
Case Study
Overcoming patient concerns and accelerating enrollment in a hard-to-recruit autoimmune study
Jul 6, 2026
Case Study
Overcoming patient concerns and accelerating enrollment in a hard-to-recruit autoimmune study
Jul 6, 2026
Case Study
Case study: Overcoming patient concerns and accelerating enrollment in a hard-to-recruit autoimmune study
Jul 6, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Article
Case Study: Turning urgency into progress—Advancing new hope in AML
Jun 4, 2026
Case Study
Case study: Speed meets excellence in global tuberculosis research
May 6, 2026
Related Insights
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
Blog
The future of patient recruitment: Building a more connected ecosystem
Sep 9, 2026
Case Study
Overcoming patient concerns and accelerating enrollment in a hard-to-recruit autoimmune study
Jul 6, 2026
Case Study
Overcoming patient concerns and accelerating enrollment in a hard-to-recruit autoimmune study
Jul 6, 2026
Case Study
Case study: Overcoming patient concerns and accelerating enrollment in a hard-to-recruit autoimmune study
Jul 6, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Article
Case Study: Turning urgency into progress—Advancing new hope in AML
Jun 4, 2026
Case Study
Case study: Speed meets excellence in global tuberculosis research
May 6, 2026